Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifalazil in uncomplicated genital Chlamydia trachomatis infection
NCT01631201Phase 2Completed
- Sponsor
- ActivBiotics
- Start
- Jul 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifalazil in Chlamydia trachomatis infection, sponsored by ActivBiotics. Started Jul 2012; status: completed.
02
Drugs
rifalazil
03
Conditions
Chlamydia trachomatis infection
Beyond the preview
Go deeper on NCT01631201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631201.